Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study

Jakob Kjærgaard; Carsten Bogh Juhl; Peter Lange; Torgny Wilcke

doi:10.1136/bmjresp-2020-000582

Article info

XML

Chronic obstructive pulmonary disease

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study

Authors

Jakob Kjærgaard Department of Internal Medicine, Respiratory Section, Herlev and Gentofte Hospital, Copenhagen University, Hellerup, Denmark PubMed articles Google scholar articles
Carsten Bogh Juhl Department of Physiotherapy and Occupational Therapy, Herlev and Gentofte Hospitals, University of Copenhagen, Hellerup, DenmarkResearch Unit for Musculoskeletal Function and Physiotherapy, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark, Odense, Syddanmark, Denmark PubMed articles Google scholar articles
Peter Lange Section of Epidemiology, Institute of Public Health, University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark PubMed articles Google scholar articles
Torgny Wilcke Department of Internal Medicine, Respiratory Section, Herlev and Gentofte Hospital, Copenhagen University, Hellerup, Denmark PubMed articles Google scholar articles

Correspondence to Dr Jakob Kjærgaard; jakob{at}naj.dk

View Full Text

Citation

Kjærgaard J, Juhl CB, Lange P, et al

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study

BMJ Open Respiratory Research 2020;7:e000582. doi: 10.1136/bmjresp-2020-000582

Publication history

Received February 26, 2020
Revised July 24, 2020
Accepted July 24, 2020
First published August 19, 2020.

Online issue publication

November 15, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.